The Precision Peptide Company Inc. (CSE:BPC)
Canada · Delayed Price · Currency is CAD 0.4600
-0.0050 (-1.08%)
Jun 23, 2026, 11:08 AM EST
CSE:BPC Income Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 0.09 | 0.05 | 0.01 | 0.29 | 0.58 | 0.12 | |
Revenue Growth (YoY) | 2116.42% | 307.47% | -95.73% | -50.84% | 394.79% | - |
Cost of Revenue | 0.04 | 0.03 | 0.07 | 0.32 | 0.54 | 0.13 |
Gross Profit | 0.06 | 0.02 | -0.06 | -0.03 | 0.04 | -0.01 |
Selling, General & Admin | 2.62 | 2.16 | 0.79 | 1.23 | 0.82 | 0.28 |
Research & Development | 0.06 | 0.03 | 0.03 | - | - | - |
Operating Expenses | 3.55 | 2.27 | 0.96 | 1.61 | 0.94 | 0.28 |
Operating Income | -3.49 | -2.25 | -1.02 | -1.64 | -0.9 | -0.3 |
Interest & Investment Income | 0.01 | 0.01 | - | - | - | - |
Currency Exchange Gain (Loss) | 0 | -0.03 | 0 | -0.01 | -0.01 | -0 |
Other Non Operating Income (Expenses) | - | - | - | - | -0.19 | - |
EBT Excluding Unusual Items | -3.48 | -2.28 | -1.02 | -1.65 | -1.09 | -0.3 |
Impairment of Goodwill | -0.88 | -0.88 | - | - | - | - |
Asset Writedown | -1.37 | -1.37 | -0.01 | -0.01 | -0.04 | - |
Pretax Income | -5.73 | -4.53 | -1.03 | -1.66 | -1.13 | -0.3 |
Net Income | -5.73 | -4.53 | -1.03 | -1.66 | -1.13 | -0.3 |
Net Income to Common | -5.73 | -4.53 | -1.03 | -1.66 | -1.13 | -0.3 |
Shares Outstanding (Basic) | 30 | 22 | 7 | 6 | 5 | 1 |
Shares Outstanding (Diluted) | 30 | 22 | 7 | 6 | 5 | 1 |
Shares Change (YoY) | 326.12% | 224.08% | 17.56% | 24.54% | 589.41% | - |
EPS (Basic) | -0.19 | -0.21 | -0.15 | -0.29 | -0.25 | -0.45 |
EPS (Diluted) | -0.19 | -0.21 | -0.15 | -0.29 | -0.25 | -0.45 |
Free Cash Flow | -2.73 | -2.33 | -0.44 | -0.98 | -0.72 | -0.95 |
Free Cash Flow Per Share | -0.09 | -0.11 | -0.07 | -0.17 | -0.16 | -1.43 |
Gross Margin | 61.96% | 44.15% | - | -11.48% | 7.04% | -10.69% |
Operating Margin | -3764.63% | -4529.94% | -8354.01% | -575.40% | -154.78% | -252.00% |
Profit Margin | -6179.87% | -9104.28% | -8450.19% | -581.35% | -194.13% | -252.86% |
Free Cash Flow Margin | -2944.71% | -4694.10% | -3601.16% | -343.39% | -123.69% | -808.45% |
EBITDA | -3.38 | -2.16 | -1.02 | -1.64 | -0.9 | -0.29 |
EBITDA Margin | - | - | - | - | -154.64% | -250.67% |
D&A For EBITDA | 0.11 | 0.09 | 0 | 0 | 0 | 0 |
EBIT | -3.49 | -2.25 | -1.02 | -1.64 | -0.9 | -0.3 |
EBIT Margin | - | - | - | - | -154.78% | -252.00% |
Advertising Expenses | - | 0.59 | 0.04 | 0.38 | 0.27 | - |